What’s going on for the future of R&D programmes
by Giuliana Miglierini After the European elections of June 2024, a vivid debate arose between the R&I stakeholders…
EIPG Meeting in Rome in April
By Piero Iamartino The 2024 General Assembly of EIPG (European Industrial Pharmacists Group) was held in Rome on…
Reform of pharma legislation: the debate on regulatory data protection
by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
Environmental sustainability: the EIPG perspective
Piero Iamartino Although the impact of medicines on the environment has been highlighted since the 70s of the…
Reactions to the proposed ban of PFAS
by Giuliana Miglierini A proposal to ban around 10,000 per- and polyfluoroalkyl substances (PFAS) was submitted in January…
EC Communication (part 1): How to address critical medicines shortages
by Giuliana Miglierini As announced on 3 October in the speech given by Commissioner Stella Kyriakides at European…